Gootz T D, Sanders C C, Goering R V
J Infect Dis. 1982 Jul;146(1):34-42. doi: 10.1093/infdis/146.1.34.
Studies were performed to characterize resistance to cefamandole in two strains of Enterobacter cloacae. Susceptible wild-type cells were exposed either to cefamandole to select stably resistant mutants or to cefoxitin to induce unstable resistance. The two types of resistant cells inactivated cefamandole, and their beta-lactamases had identical isoelectric focusing patterns and substrate profiles. Studies of the beta-lactamases of these resistant cells indicated that the enzymes belonged to the Richmond and Sykes Group I and suggested that their production in wild-type cells is under repressor control. The resistant mutants appeared to be stably derepressed at the locus for beta-lactamase expression, whereas cefoxitin-induced cells were reversibly derepressed wild-type cells. Transfer of plasmids from one mutant colony to recipient Escherichia coli cells did not transfer resistance. These two types of resistance to cefamandole may explain the widely discrepant results obtained during in vitro and in vivo studies, as well as the rapid emergence of resistance that has been observed during clinical use.
开展了多项研究,以表征阴沟肠杆菌两株菌株对头孢孟多的耐药性。将敏感野生型细胞分别暴露于头孢孟多以筛选稳定耐药突变体,或暴露于头孢西丁以诱导不稳定耐药性。这两种耐药细胞均使头孢孟多失活,且它们的β-内酰胺酶具有相同的等电聚焦图谱和底物谱。对这些耐药细胞的β-内酰胺酶研究表明,这些酶属于里士满和赛克斯I组,并提示它们在野生型细胞中的产生受阻遏物控制。耐药突变体似乎在β-内酰胺酶表达位点稳定地去阻遏,而头孢西丁诱导的细胞是可逆去阻遏的野生型细胞。将质粒从一个突变菌落转移至受体大肠杆菌细胞并未转移耐药性。这两种对头孢孟多的耐药性类型可能解释了在体外和体内研究中获得的差异很大的结果,以及在临床使用期间观察到的耐药性的迅速出现。